Pralidoxime for reducing nicotinic cholinergic morbidity in organophosphate poisoning.
Patial
R K
RK
Kapoor
D
D
D000931:Antidotes / Q000627:therapeutic use*; D002801:Cholinesterase Reactivators / Q000627:therapeutic use*; D006801:Humans; D007306:Insecticides / Q000506:poisoning*; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000503:physiopathology; D018722:Nicotinic Agonists / Q000627:therapeutic use; D009943:Organophosphorus Compounds; D011220:Pralidoxime Compounds / Q000627:therapeutic use*
D000931:Antidotes; D002801:Cholinesterase Reactivators; D007306:Insecticides; D018722:Nicotinic Agonists; D009943:Organophosphorus Compounds; D011220:Pralidoxime Compounds; C028797:pralidoxime